Endoscopic Metabolic and Bariatric Therapies

NCT ID: NCT05725967

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-08

Study Completion Date

2029-05-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Investigators will be collecting data on bariatric patients post-bariatric surgery, post-endoscopic revision of bariatric surgical complications and post-endoscopic metabolic and bariatric therapies (including but not limited to roux-en-y gastric bypass, sleeve gastrectomy, laparoscopic adjustable gastric banding, gastroplasty with endoscopic myotomy (GEM), endoscopic sleeve gastroplasty (ESG), transoral outlet reduction (TORe), primary obesity surgery endoluminal (POSE), restorative obesity surgery endoluminal (ROSE), intragastric balloons (IGB), aspiration therapy and pylorus sparing antral myotomy) to review demographics, adverse events, medications, radiology, procedure time, cost, comorbidity resolution and resource utilization.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Obesity, Morbid Obesity Associated Disorder Bariatric Surgery Candidate Fistula, Gastric Roux-en-y Anastomosis Site Ulcer, Gastric Abdominal Pain Abdominal Obesity Complication of Surgical Procedure Complication of Treatment Complication,Postoperative Weight Gain Weight Loss Leak, Anastomotic Delayed Gastric Emptying Following Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary Obesity Endoscopic Procedures

Primary endoscopic procedures for treatment of obesity.

Primary Obesity Endoscopic Procedures

Intervention Type PROCEDURE

Any primary endoscopic procedure for treatment of obesity including endoscopic sleeve gastroplasty (ESG), intragastric balloons (IGB), Aspiration therapy, pylorus sparing antral myotomy (PSAM), primary obesity surgery endoluminal (POSE), gastroplasty with endoscopic myotomy (GEM).

Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction

Intervention Type DEVICE

Any endoscopic procedure using an endoscopic suturing device for primary obesity treatment or revision of post bariatric complications.

Intragastric Balloon

Intervention Type DEVICE

An endoscopic bariatric procedure involving the placement of an intragastric balloon.

Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal

Intervention Type DEVICE

Any endoscopic procedure using an endoscopic plicating device for primary obesity treatment or revision of post bariatric complications.

Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy

Intervention Type DEVICE

Electrosurgical interventions for obesity. Use of electrosurgical devices, such as electrocautery for the primary treatment of obesity or obesity related complications.

Aspiration Therapy

Intervention Type DEVICE

Placement of an aspiration therapy device for the treatment of obesity.

Endoscopic Revision of Bariatric Surgical Procedures

Endoscopic revision of post-bariatric surgical complications.

Endoscopic Revision of Bariatric Surgical Procedures

Intervention Type PROCEDURE

Any endoscopic revision procedure in a post-bariatric surgical patient, including transoral outlet reduction (TORe), restorative obesity surgery endoluminal (ROSE), argon plasma coagulation of the outlet (APC), endoscopic suturing.

Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction

Intervention Type DEVICE

Any endoscopic procedure using an endoscopic suturing device for primary obesity treatment or revision of post bariatric complications.

Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal

Intervention Type DEVICE

Any endoscopic procedure using an endoscopic plicating device for primary obesity treatment or revision of post bariatric complications.

Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy

Intervention Type DEVICE

Electrosurgical interventions for obesity. Use of electrosurgical devices, such as electrocautery for the primary treatment of obesity or obesity related complications.

Bariatric Surgery Procedures

Bariatric surgical procedures.

Bariatric Surgery Procedures

Intervention Type PROCEDURE

Any bariatric surgical procedure including Roux-en-Y gastric bypass (RYGB), laparoscopic sleeve gastroplasty (LSG), laparoscopic adjustable gastric banding (LAGB)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Primary Obesity Endoscopic Procedures

Any primary endoscopic procedure for treatment of obesity including endoscopic sleeve gastroplasty (ESG), intragastric balloons (IGB), Aspiration therapy, pylorus sparing antral myotomy (PSAM), primary obesity surgery endoluminal (POSE), gastroplasty with endoscopic myotomy (GEM).

Intervention Type PROCEDURE

Endoscopic Revision of Bariatric Surgical Procedures

Any endoscopic revision procedure in a post-bariatric surgical patient, including transoral outlet reduction (TORe), restorative obesity surgery endoluminal (ROSE), argon plasma coagulation of the outlet (APC), endoscopic suturing.

Intervention Type PROCEDURE

Bariatric Surgery Procedures

Any bariatric surgical procedure including Roux-en-Y gastric bypass (RYGB), laparoscopic sleeve gastroplasty (LSG), laparoscopic adjustable gastric banding (LAGB)

Intervention Type PROCEDURE

Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction

Any endoscopic procedure using an endoscopic suturing device for primary obesity treatment or revision of post bariatric complications.

Intervention Type DEVICE

Intragastric Balloon

An endoscopic bariatric procedure involving the placement of an intragastric balloon.

Intervention Type DEVICE

Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal

Any endoscopic procedure using an endoscopic plicating device for primary obesity treatment or revision of post bariatric complications.

Intervention Type DEVICE

Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy

Electrosurgical interventions for obesity. Use of electrosurgical devices, such as electrocautery for the primary treatment of obesity or obesity related complications.

Intervention Type DEVICE

Aspiration Therapy

Placement of an aspiration therapy device for the treatment of obesity.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ESG, Aspiration Therapy, IGB, POSE, GEM, PSAM, BEAM, EMBTs TORe, ROSE, APC RYGB, LSG, LAGB ESG, TORe IGB POSE, ROSE APC, GEM, BEAM, PSAM Aspire

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients from Mass General Brigham
* any patient having an endoscopic primary obesity procedure
* any patient having an endoscopic post-bariatric surgical revision procedure
* any patient having a bariatric surgical procedure

Exclusion Criteria

* patients without past surgical and medical history medical records in the Mass General Brigham system
* patients unwilling to allow for medical record review at Mass General Brigham
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Christopher C. Thompson, MD, MSc

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christopher C. Thompson, MD, MSc

Director of Endoscopy

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher C. Thompson, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

Brigham and Women's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Abu Dayyeh BK, Bazerbachi F, Vargas EJ, Sharaiha RZ, Thompson CC, Thaemert BC, Teixeira AF, Chapman CG, Kumbhari V, Ujiki MB, Ahrens J, Day C; MERIT Study Group; Galvao Neto M, Zundel N, Wilson EB. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022 Aug 6;400(10350):441-451. doi: 10.1016/S0140-6736(22)01280-6. Epub 2022 Jul 28.

Reference Type BACKGROUND
PMID: 35908555 (View on PubMed)

Jirapinyo P, Thompson CC. Endoscopic gastric plication for the treatment of weight regain after Roux-en-Y gastric bypass (with video). Gastrointest Endosc. 2022 Jul;96(1):51-56. doi: 10.1016/j.gie.2022.02.051. Epub 2022 Mar 5.

Reference Type BACKGROUND
PMID: 35259393 (View on PubMed)

de Moura DTH, Hirsch BS, Boghossian MB, de Medeiros FS, McCarty TR, Thompson CC, de Moura EGH. Low-cost modified endoscopic vacuum therapy using a triple-lumen tube allows nutrition and drainage for treatment of an early post-bariatric surgery leak. Endoscopy. 2022 Jul;54(7):E376-E377. doi: 10.1055/a-1540-5870. Epub 2021 Aug 9. No abstract available.

Reference Type BACKGROUND
PMID: 34374043 (View on PubMed)

de Moura DTH, de Freitas Junior JR, de Souza GMV, de Oliveira GHP, McCarty TR, Thompson CC, de Moura EGH. Endoscopic management of acute leak after sleeve gastrectomy: principles and techniques. Endoscopy. 2022 Jul;54(7):E327-E328. doi: 10.1055/a-1525-1661. Epub 2021 Jul 9. No abstract available.

Reference Type BACKGROUND
PMID: 34243196 (View on PubMed)

Sanchez-Luna SA, Thompson CC, De Moura EGH, de Medeiros FS, De Moura DTH. Modified endoscopic vacuum therapy: Are we ready for prime time? Gastrointest Endosc. 2022 Jun;95(6):1281-1282. doi: 10.1016/j.gie.2021.12.049. No abstract available.

Reference Type BACKGROUND
PMID: 35589208 (View on PubMed)

Bazarbashi AN, Dolan RD, McCarty TR, Jirapinyo P, Thompson CC. Endoscopic revision of gastrojejunal anastomosis for the treatment of dumping syndrome in patients with Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Endosc. 2022 Jun;36(6):4099-4107. doi: 10.1007/s00464-021-08731-4. Epub 2021 Oct 20.

Reference Type BACKGROUND
PMID: 34669046 (View on PubMed)

Jirapinyo P, Thompson CC. Primary Bariatric Procedures. Dig Dis Sci. 2022 May;67(5):1674-1687. doi: 10.1007/s10620-022-07393-z. Epub 2022 Mar 29.

Reference Type BACKGROUND
PMID: 35348970 (View on PubMed)

Argueta PP, Salazar M, Vargo JJ, Chahal P, Rodriguez JJ, Simons-Linares CR, Thompson CC. Thirty-Day Readmission After Bariatric Surgery: Causes, Effects on Outcomes, and Predictors. Dig Dis Sci. 2022 Mar;67(3):834-843. doi: 10.1007/s10620-021-06934-2. Epub 2021 Jun 24.

Reference Type BACKGROUND
PMID: 34169433 (View on PubMed)

Jirapinyo P, McCarty TR, Dolan RD, Shah R, Thompson CC. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 Mar;20(3):511-524.e1. doi: 10.1016/j.cgh.2021.03.017. Epub 2021 Mar 13.

Reference Type BACKGROUND
PMID: 33727164 (View on PubMed)

Singh S, Bazarbashi AN, Khan A, Chowdhry M, Bilal M, de Moura DTH, Jirapinyo P, Thakkar S, Thompson CC. Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis. Surg Endosc. 2022 Jan;36(1):252-266. doi: 10.1007/s00464-020-08267-z. Epub 2021 Feb 1.

Reference Type BACKGROUND
PMID: 33523277 (View on PubMed)

Thompson CC, Jirapinyo P, Shah R, Simsek C. Gastroplasty With Endoscopic Myotomy (GEM) for the Treatment of Obesity: Preliminary Efficacy and Physiologic Results. Gastroenterology. 2022 Nov;163(5):1173-1175. doi: 10.1053/j.gastro.2022.07.077. Epub 2022 Aug 10. No abstract available.

Reference Type RESULT
PMID: 35961376 (View on PubMed)

Jirapinyo P, Thompson CC. Comparison of distal primary obesity surgery endolumenal techniques for the treatment of obesity (with videos). Gastrointest Endosc. 2022 Sep;96(3):479-486. doi: 10.1016/j.gie.2022.04.1346. Epub 2022 May 11.

Reference Type RESULT
PMID: 35568242 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022P001757

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Bariatric Surgery
NCT02857179 RECRUITING
Omentectomy and Metabolic Syndrome
NCT00923260 COMPLETED NA